PANAL HUGG ULT-CONF NINA E3 C40 COMPROEXPO FABRICANTE: QUIFA - PERRIGO

Description

FABRICANTE: QUIFA - PERRIGO

Monitorear función cardíaca antes y durante el tratamiento

DOSIS: 400 MG

PRINCIPIO ACTIVO: TEOFILINA

un agente inmunomodulador indicado para el tratamiento de la hepatitis viral crónica

PANAL HUGG ULT-CONF NINA E3 C40 COMPROEXPO FABRICANTE: QUIFA - PERRIGO40 Piezas Bolsa

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy